In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Working Group on Thrombosis



Platelets and coagulation factors have diverse roles in many cardiovascular diseases and basic and clinical research in this area has led to marked improvements in clinical outcomes such as in patients with atherothrombotic events or atrial fibrillation. The pathways involved in thrombosis and haemostasis also play important roles in vascular inflammation and wound healing. The evolving complexities of the science and available treatments for management and prevention of thrombosis, as well as the requirements for yet more effective treatments, drive the need for ongoing dissemination of knowledge and development of consensus amongst both practising physicians and research scientists.

It is this need that the ESC Working Group on Thrombosis aims to meet.

Prof. Bianca Rocca (Italy)
Chairperson 2016-2018


Aims and Activities

  • Enhance knowledge of thrombosis in clinical cardiology in Europe.
  • Stimulate postgraduate education in thrombosis both at the European Congress of Cardiology and beyond.
  • Stimulate clinical research in thrombosis in clinical cardiology in Europe, to be performed preferably by young investigators.
  • Stimulate basic research on thrombosis in order to increase our knowledge on the pathophysiology to initiate the development of new preventive and therapeutic tools.
  • Bridge basic science in these areas with the clinical practice of Cardiology.
  • Produce consensus in order to influence current clinical practice of Cardiology in Europe with regard to drugs or treatments intervening on vascular biology and blood vessel-wall interactions".